Bioxytran Inc at Diamond Equity Emerging Growth International Conference (Virtual) Transcript
All right. Next up, we have Bioxytran Inc. They're on the OTCQB trading under the ticker symbol BIXT. The company is a clinical-stage biotech with two revolutionary platform technologies. They have an oral glycovirology drug that recently completed clinical trials and achieved 100% viral reduction in seven days, a feat only accomplished by one other drug in the past decade.
Their drug is a galectin inhibitor that neutralizes the COVID-19 virus and prevents it from entering cells. They also have another platform drug being developed to treat strokes. So due to the molecule's small size, it has the ability to carry oxygen into areas of poor circulation.
Questions & Answers
But before we get into the heart of the interview, Mike, nice to see you again. Mike Sheikh, I'd like you to address the elephant in the room about COVID, right? Everyone's still talking about it.
Now, earlier this year, President Biden indicated the public health emergency would expire
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
